222 related articles for article (PubMed ID: 10666803)
1. Erythema migrans in the immunocompromised host.
Maraspin V; Lotric-Furlan S; Cimperman J; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):923-32. PubMed ID: 10666803
[TBL] [Abstract][Full Text] [Related]
2. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
Maraspin V; Lotric-Furlan S; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
[TBL] [Abstract][Full Text] [Related]
3. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin.
Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):498-504. PubMed ID: 12422590
[TBL] [Abstract][Full Text] [Related]
4. Solitary borrelial lymphocytoma in adult patients.
Maraspin V; Cimperman J; Lotric-Furlan S; Ruzić-Sabljić E; Jurca T; Picken RN; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):515-23. PubMed ID: 12422593
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
[TBL] [Abstract][Full Text] [Related]
6. Lyme borreliosis and peripheral facial palsy.
Lotric-Furlan S; Cimperman J; Maraspin V; Ruzić-Sabljić E; Logar M; Jurca T; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):970-5. PubMed ID: 10666811
[TBL] [Abstract][Full Text] [Related]
7. Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.
Hunfeld KP; Ruzić-Sabljić E; Norris DE; Kraiczy P; Strle F
Int J Med Microbiol; 2006 May; 296 Suppl 40():233-41. PubMed ID: 16530006
[TBL] [Abstract][Full Text] [Related]
8. Clinical and epidemiological findings for patients with erythema migrans. Comparison of cohorts from the years 1993 and 2000.
Strle F; Videcnik J; Zorman P; Cimperman J; Lotric-Furlan S; Maraspin V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):493-7. PubMed ID: 12422589
[TBL] [Abstract][Full Text] [Related]
9. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
[TBL] [Abstract][Full Text] [Related]
10. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease.
Dattwyler RJ; Luft BJ; Kunkel MJ; Finkel MF; Wormser GP; Rush TJ; Grunwaldt E; Agger WA; Franklin M; Oswald D; Cockey L; Maladorno D
N Engl J Med; 1997 Jul; 337(5):289-94. PubMed ID: 9233865
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic findings in patients with erythema migrans.
Pikelj-Pecnik A; Lotric-Furlan S; Maraspin V; Cimperman J; Logar M; Jurca T; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):510-4. PubMed ID: 12422592
[TBL] [Abstract][Full Text] [Related]
12. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
Fürst B; Glatz M; Kerl H; Müllegger RR
Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
[TBL] [Abstract][Full Text] [Related]
13. Treatment of erythema migrans with doxycycline for 7 days versus 14 days in Slovenia: a randomised open-label non-inferiority trial.
Stupica D; Collinet-Adler S; Blagus R; Gomišček A; Cerar Kišek T; Ružić-Sabljić E; Velušček M
Lancet Infect Dis; 2023 Mar; 23(3):371-379. PubMed ID: 36209759
[TBL] [Abstract][Full Text] [Related]
14. [Stage-oriented treatment of Lyme borreliosis].
Fingerle V; Wilske B
MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
[TBL] [Abstract][Full Text] [Related]
15. Erythema migrans in pregnancy.
Maraspin V; Cimperman J; Lotric-Furlan S; Pleterski-Rigler D; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):933-40. PubMed ID: 10666804
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
17. Lyme meningitis: a one-year follow up controlled study.
Cimperman J; Maraspin V; Lotric-Furlan S; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):961-3. PubMed ID: 10666809
[TBL] [Abstract][Full Text] [Related]
18. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
Egberts F; Möller M; Proksch E; Schwarz T
J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
[TBL] [Abstract][Full Text] [Related]
19. [Lyme borreliosis].
Weiss M
Ther Umsch; 1998 Jan; 55(1):45-51. PubMed ID: 9492618
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology and therapy of Lyme arthritis and other manifestations of Lyme borreliosis in Germany: results of a nation-wide survey].
Priem S; Munkelt K; Franz JK; Schneider U; Werner T; Burmester GR; Krause A
Z Rheumatol; 2003 Oct; 62(5):450-8. PubMed ID: 14579032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
